Medindia on MSN
One Cancer Cell in Blood? New Test Spots It Early
Infrared spectroscopy-based liquid biopsy detects even one lung cancer cell in blood, enabling earlier diagnosis, easier ...
Live Science on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It ...
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunes ...
A new survey of UK radiologists finds that 100% of NHS trusts have now used pre-biopsy MRI, although variations persist in ...
A mum-of-two was diagnosed with breast cancer after she had a gut instinct to squeeze her left breast in the shower and felt ...
ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...
BillionToOne saw rapid growth in molecular diagnostics, strong Q3 results, and evolving valuation. Read here for more ...
THE “magic” of Christmas is something Matt Ridout can no longer stomach. It’s yet another painful reminder that his beautiful ...
The MCED test shows similar performance in cancer survivors and the general population, with a PPV of 50% and high ...
TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive ...
As of Tuesday, December 23, Burning Rock Biotech Limited’s BNR share price has dipped by 9.53%, which has investors questioning if this is right time to buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback